Ignite Creation Date:
2024-05-05 @ 6:54 PM
Last Modification Date:
2024-10-26 @ 9:38 AM
Study NCT ID:
NCT00566423
Status:
COMPLETED
Last Update Posted:
2011-06-23
First Post:
2007-11-29
Brief Title:
Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension PAH
Sponsor:
Northwell Health
Organization:
Northwell Health
Study Overview
Official Title:
Biomarkers in the Diagnosis and Assessment of PAH
Status:
COMPLETED
Status Verified Date:
2011-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Biomarkers
Brief Summary:
The investigators hypothesize that baseline plasma brain natriuretic peptide BNP and migration inhibitory factor MIF levels are surrogate markers of clinical severity of PAH and that changes in plasma brain natriuretic peptide BNP and MIF levels pre and post exercise
Detailed Description:
As above
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NS-LIJHS IRB 07-030 | None | None | None |